Handelsbanken Fonder
ICPT

Handelsbanken Fonder’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Handelsbanken Fonder’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,165
Closed -$196K – 1769
2021
Q3 		$196K Hold
13,165
– – ﹤0.01% 1658
2021
Q2 		$263K Buy
+13,165
New +$261K ﹤0.01% 1662
2020
Q3 		– Sell
-4,765
Closed -$228K – 1475
2020
Q2 		$228K Buy
+4,765
New +$368K ﹤0.01% 1344

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Handelsbanken Fonder's ICPT Position: Q4 2021 in Review

Handelsbanken Fonder sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2021, closing a stake of 13,165 shares — an estimated $196K sold.

Handelsbanken Fonder first reported a position in ICPT in Q2 2020 and held it in 3 quarters. The position peaked at $263K in Q2 2021. 147 funds tracked by Wall St. Rank hold ICPT as of Q4 2021.

  • Handelsbanken Fonder reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Handelsbanken Fonder sold 13,165 Intercept Pharmaceuticals, Inc. shares in Q4 2021, an estimated $196K.
  • Handelsbanken Fonder first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2020 and held it in 3 quarters.
  • Handelsbanken Fonder's Intercept Pharmaceuticals, Inc. position peaked at $263K in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2021.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.